// App-Quantinova.ai

: The Pros and Cons of Splenectomy in Transfusion Dependent Thalassemia Patient

Researchers

Presenter

  • Adisak Tantiworawit

Principal Investigators

  • Somying Dumnil

  • Nichanan Osataphan

  • Thanawat Rattanathammethee

  • Sasinee Hantrakool

  • Chatree Chai-Adisaksopha

  • Ekarat Rattarittamrong

  • Lalita Norasetthada

  • Pimlak Charoenkwan

Medical Centers

  • Division of Hematology, Faculty of Medicine, Chiang Mai University, Muang, Chiang Mai, Thailand

  • Department of Surgery, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

Locations

  • Thailand

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Cardiovascular (CVS)

  • Genetic Disorder

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Pulmonary arterial hypertension

  • Hemochromatosis

  • Hypertension

  • Thalassemia

  • Venous thrombosis

Biomarkers

  • Tumor doubling time

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A